Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Organon Teknika was a prominent life sciences company specializing in anesthesiology and in vitro diagnostics. As a subsidiary of Akzo Nobel, it gained international recognition for developing essential neuromuscular blocking agents such as Norcuron and Zemuron. The company also played a significant role in the diagnostics field, particularly with its Nucleic Acid Sequence Based Amplification (NASBA) technology used for detecting HIV-1 and other pathogens. In 2001, the diagnostics division was acquired by bioMérieux, while the pharmaceutical operations were eventually integrated into Merck & Co. following a series of mergers. The company was headquartered in Boxtel, Netherlands, and maintained a significant presence in Durham, North Carolina.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Organon Teknika.